Stay updated on Biomarker Study in Melanoma: Nivolumab + Ipilimumab Clinical Trial

Sign up to get notified when there's something new on the Biomarker Study in Melanoma: Nivolumab + Ipilimumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Biomarker Study in Melanoma: Nivolumab + Ipilimumab Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page footer/release label was updated from **Revision: v3.5.2** to **Revision: v3.5.3**, reflecting a general site/version update rather than a change to the clinical trial details.
    Difference
    0.1%
    Check dated 2026-04-24T05:49:24.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The page revision has been updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:29:42.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.3 to v3.5.0 in the page header; the update does not alter study details or results.
    Difference
    0.1%
    Check dated 2026-03-19T06:00:09.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Added page revision label Revision: v3.4.3; removed Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T00:01:25.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    No substantive content changes detected; the page content appears unchanged.
    Difference
    0.1%
    Check dated 2026-03-04T22:47:22.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed older notices (including the government funding lapse alert and Revision: v3.4.1). These are maintenance-related changes and do not affect the study details.
    Difference
    0.4%
    Check dated 2026-02-11T14:11:53.000Z thumbnail image

Stay in the know with updates to Biomarker Study in Melanoma: Nivolumab + Ipilimumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Biomarker Study in Melanoma: Nivolumab + Ipilimumab Clinical Trial page.